Dr. Dongli Lu | Glycobiology | Best Researcher Award
Project Scientist, Cedars Sinai Medical Center, United States
Dr. Dongli Lu is a distinguished scientist specializing in structural glycobiology and mass spectrometry. Currently serving as a Project Scientist in the MAST program at Cedars-Sinai Medical Center, Dr. Lu brings expertise in cutting-edge techniques for glycomics and proteomics research. With a robust background in academia and a passion for advancing cancer therapeutics, Dr. Lu has significantly contributed to understanding glycan biology, pregnancy-specific proteins, and therapeutic targets for cancer biomarkers. 🌟🔬
Publication Profile
Google Scholar
Education 🎓🌍
Dr. Lu holds a Ph.D. in Structural Glycobiology from Imperial College London (2019), where he conducted groundbreaking research in mass spectrometry. He also earned a Master of Science in Applied Biosciences and Biotechnology from the same institution (2014). His academic journey began with dual bachelor’s degrees: a Bachelor of Science in Crop and Soil Sciences from Michigan State University (2013) and a Bachelor of Agriculture in Grassland Science from Sichuan Agricultural University (2013). 🎓🧬
Experience 🏛️🔬
Dr. Lu’s professional journey includes his current role as a Project Scientist at Cedars-Sinai Medical Center. Previously, he was a postdoctoral research fellow at Beth Israel Deaconess Medical Center, Harvard Medical School (2021–2024), where he focused on mass spectrometry-based glycobiology. He has contributed to numerous high-impact research projects, particularly in glycomics and glycoproteomics investigations, to develop cancer vaccines and optimize therapeutic proteins. 🌟🔍
Research Interests 🔍💡
Dr. Lu’s research interests revolve around structural glycobiology, glycomics, glycoproteomics, and their applications in cancer therapeutics, biomarker discovery, and immunology. He is passionate about leveraging advanced mass spectrometry techniques to uncover novel insights into glycan biology and their therapeutic potential. 🧪🌌
Awards and Recognitions 🏆🌟
Dr. Lu has been recognized for his significant contributions to the field of glycobiology, earning accolades for his innovative research in glycomics and proteomics. His scholarly work has garnered attention in prominent journals and collaborations across international institutions. 🏅✨
Publications 📄🔗
Blundell, P. A., Lu, D., Wilkinson, M., Dell, A., Haslam, S., & Pleass, R. J. (2019). Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers. Journal of Immunology, 202, 1595-1611. Cited by: 80.
Mendoza M, Lu D†, Ballesteros A, et al. (2020). Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand. Glycobiology, 30(11), 895-909. †Equal co-first authorship. Cited by: 65.
Blundell, P. A., Lu, D., Dell, A., Haslam, S., & Pleass, R. J. (2020). Choice of host cell line is essential for the functional glycosylation of the fragment crystallizable region. Journal of Immunology, 204, 1022-1034. Cited by: 52